{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:01:57Z","timestamp":1748538117696},"reference-count":41,"publisher":"Springer Publishing Company","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:p>Hepatitis B viral infection is a significant source of morbidity and mortality worldwide. The United States has experienced a precipitous drop in acute hepatitis B infection after the introduction and widespread adoption of recombinant vaccines. Neonates experience significant risk from both vertical and horizontal hepatitis B exposure during a period of immaturity of the innate and adaptive immune systems. Acquisition of hepatitis B virus at or near birth confers the highest lifetime risk of chronic infection and subsequent complications including liver cirrhosis and hepatocellular carcinoma. Pregnant women should be screened for the presence of hepatitis B surface antigen, indicating acute or chronic infection, and, if positive, hepatitis B viral deoxyribonucleic acid, allowing for quantification of viral load. The development of highly effective and safe recombinant vaccines allows partial protection of late preterm and term neonates immediately after birth. Additionally, administration of hepatitis B immune globulin in the setting of suspected or confirmed exposure supplements the immune response and decreases the risk of chronic infection. The optimal timing of vaccination is later in low-birth-weight neonates due to the aforementioned immune system immaturity. Health care providers serving neonates must familiarize themselves with national guidelines regarding hepatitis B vaccination and hepatitis B immune globulin therapy. Understanding the risks of infection and the evidence basis supporting vaccination and immunotherapy will allow providers to educate families and support decision-making, with the potential to eradicate this vaccine-preventable illness in our lifetime.<\/jats:p>","DOI":"10.1891\/nn-2023-0035","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:20:24Z","timestamp":1700814024000},"page":"348-355","source":"Crossref","is-referenced-by-count":1,"title":["Bad Liver and a Broken Heart: Hepatitis B in the Newborn"],"prefix":"10.1891","volume":"42","author":[{"given":"Christopher","family":"McPherson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"2023112400350598000_42.6.348.1","unstructured":"World Health Organization. Hepatitis B. 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"2023112400350598000_42.6.348.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00315-8"},{"key":"2023112400350598000_42.6.348.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30579-7"},{"key":"2023112400350598000_42.6.348.4","unstructured":"Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV, Centers for Disease Control and Prevention, Viral Hepatitis, STD, and TB Prevention. 2021 National viral hepatitis progress report . 2021. https:\/\/www.cdc.gov\/hepatitis\/policy\/npr\/2021\/NationalProgressReport2021.html"},{"key":"2023112400350598000_42.6.348.5","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90830-A"},{"key":"2023112400350598000_42.6.348.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440090052025"},{"key":"2023112400350598000_42.6.348.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197504102921503"},{"key":"2023112400350598000_42.6.348.8","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.992"},{"key":"2023112400350598000_42.6.348.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.014"},{"key":"2023112400350598000_42.6.348.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0567"},{"key":"2023112400350598000_42.6.348.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2007.01.013"},{"key":"2023112400350598000_42.6.348.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28156"},{"issue":"6564","key":"2023112400350598000_42.6.348.13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.abi5658","article-title":"Ten millennia of hepatitis B virus evolution","volume":"374","year":"2021","journal-title":"Science"},{"key":"2023112400350598000_42.6.348.14","first-page":"20","article-title":"Eine icterus epidemic","volume":"22","year":"1885","journal-title":"Berl Klin Woschenschr"},{"issue":"1","key":"2023112400350598000_42.6.348.15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2516.1995.tb00043.x","article-title":"Hepatitis as a complication of blood transfusion","volume":"1","year":"1995","journal-title":"Haemophilia"},{"key":"2023112400350598000_42.6.348.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198010093031501"},{"key":"2023112400350598000_42.6.348.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-3-362"},{"key":"2023112400350598000_42.6.348.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212093072403"},{"issue":"6","key":"2023112400350598000_42.6.348.19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM198502073120613","article-title":"Safety of the hepatitis B vaccine","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"2023112400350598000_42.6.348.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380070075022"},{"key":"2023112400350598000_42.6.348.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(86)92668-X"},{"issue":"1","key":"2023112400350598000_42.6.348.22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(83)90005-1","article-title":"Immunogenicity of HBV vaccine in healthy Chinese children","volume":"1","year":"1983","journal-title":"Vaccine"},{"key":"2023112400350598000_42.6.348.23","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1338569"},{"key":"2023112400350598000_42.6.348.24","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200111000-00009"},{"issue":"17","key":"2023112400350598000_42.6.348.25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM197110212851702","article-title":"Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections","volume":"285","year":"1971","journal-title":"N Engl J Med"},{"issue":"21","key":"2023112400350598000_42.6.348.26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJM197511202932102","article-title":"Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute","volume":"293","year":"1975","journal-title":"N Engl J Med"},{"issue":"21","key":"2023112400350598000_42.6.348.27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM197511202932103","article-title":"Hepatitis B \"immune\" globulin: effectiveness in prevention of dialysis-associated hepatitis","volume":"293","year":"1975","journal-title":"N Engl J Med"},{"key":"2023112400350598000_42.6.348.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197511202932104"},{"issue":"26","key":"2023112400350598000_42.6.348.29","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM197412262912603","article-title":"Prevention of chronic neonatal hepatitis B virus infection with antibody to the hepatitis B surface antigen","volume":"291","year":"1974","journal-title":"N Engl J Med"},{"issue":"8243","key":"2023112400350598000_42.6.348.30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","article-title":"Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial","volume":"318","year":"1981","journal-title":"The Lancet"},{"key":"2023112400350598000_42.6.348.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390190090026"},{"issue":"4","key":"2023112400350598000_42.6.348.32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biologicals.2012.04.003","article-title":"Pathogen safety profile of a 10% IgG preparation manufactured using a depth filtration-modified process","volume":"40","year":"2012","journal-title":"Biologicals"},{"key":"2023112400350598000_42.6.348.33","doi-asserted-by":"crossref","unstructured":"Horowitz, B . Investigations into the application of tri(n-butyl)phosphate\/detergent mixtures to blood derivatives. Curr Stud Hematol Blood Transfus . 1989;56:83\u201396. https:\/\/doi.org\/10.1159\/000416559","DOI":"10.1159\/000416559"},{"key":"2023112400350598000_42.6.348.34","unstructured":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Vaccine administration: general best practice guidelines for immunization. 2023. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/administration.html"},{"key":"2023112400350598000_42.6.348.35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.e14"},{"issue":"2","key":"2023112400350598000_42.6.348.36","first-page":"52","article-title":"Response to hepatitis B vaccine in preterm babies","volume":"21","year":"2002","journal-title":"Indian J Gastroenterol"},{"key":"2023112400350598000_42.6.348.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00493-5"},{"issue":"8","key":"2023112400350598000_42.6.348.38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a117321","article-title":"Long-term follow-up of hepatitis B vaccine in infants of carrier mothers","volume":"140","year":"1994","journal-title":"Am J Epidemiol"},{"key":"2023112400350598000_42.6.348.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02000-8"},{"key":"2023112400350598000_42.6.348.40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00372"},{"key":"2023112400350598000_42.6.348.41","unstructured":"Vaccine Education Center. Children\u2019s Hospital of Philadelphia. https:\/\/www.chop.edu\/centers-programs\/vaccine-education-center"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/NN-2023-0035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:36:16Z","timestamp":1700814976000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/NN-2023-0035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11,23]]},"published-print":{"date-parts":[[2023,11,1]]}},"alternative-id":["10.1891\/NN-2023-0035"],"URL":"https:\/\/doi.org\/10.1891\/nn-2023-0035","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}